Uncovering Targeted Neural Cell Therapies for Chronic Disorders of the Nervous System

Time: 5:00 pm
day: Day 2 afternoon


  • Developing neuronal cell therapy targeting dysregulated neural activity as a broad opportunity for the potential treatment of multiple neurodegenerative and developmental disorders
  • Revealing NRTX-1001: an inhibitory neuron cell therapy for chronic focal epilepsy (Phase I/II; NCT05135091)
  • Examining the preclinical evaluation of NRTX-1001 for Alzheimer’s disease